The Journal of Pharmaceutical Policy and Practice is the official journal of the Commonwealth Pharmacists Association.
Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits
Hyperglycemia is an undisputed epidemiological risk factor for microvascular complications in both type 1 and type 2 diabetes, integral in their causal pathways. Importantly, interventions that reduce the hype...
Citation: Journal of Pharmaceutical Policy and Practice 2021 14:35